Focus on Molecular Therapeutics
Below are all the Focus articles related specifically to our Molecular Therapeutics Research Program. All Focus articles are also available.
Study Evaluates Newer Treatment for Women Whose Breast Cancer Has Spread
Results from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate with capecitabine, a standard drug used for chemotherapy today in women with previously treated metastatic breast cancer, showed that eribulin demonstrated a trend toward improved overall survival.
January 07, 2013
Can a Cancer Drug Combo Be Too Effective?
March 26, 2012
Disrupting the Pathways to Cancer
April 15, 2010
Murray Korc: Putting Principles into Practice
As both a physician and a scientist, Murray Korc, MD, strives to bring new treatments from the lab bench to the hospital bed.
January 10, 2009
